About PATHWAYS NEURO PHARMA, INC.
Pathways Neuro Pharma, Inc. is a biotechnology company focused on developing gene therapies for rare neurological disorders, particularly Juvenile Parkinson's Disease, using adeno-associated virus (AAV) delivery systems. The company aims to restore underlying biological pathways to provide disease-modifying benefits.
Development of gene therapies for rare neurological disordersUtilization of adeno-associated virus (AAV) delivery systems for CNS-targeted gene therapyDesign of durable, single-administration therapeutic expressionResearch into PINK1 gene therapy targeting inherited pathways in Juvenile Parkinson's Disease
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to PATHWAYS NEURO PHARMA, INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.